Skip to content

Efficacy and safety of ultrasound-guided short-term supraorbital electrical stimulation in the treatment of the ophthalmic branch of postherpetic trigeminal neuralgia

Efficacy and safety of ultrasound-guided short-term supraorbital electrical stimulation in the treatment of the ophthalmic branch of postherpetic trigeminal neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099240
Enrollment
Unknown
Registered
2025-03-20
Start date
2025-03-31
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes zoster trigeminal neuralgia (HZN)

Interventions

Sponsors

The Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1.The nerve area involved is the first trigeminal nerve; 2.The patient was diagnosed with PHN; 3.Visual analog scale (VAS) score >=4 points; 4.There was no significant relief of pain after non-surgical treatment (including drugs and traditional treatments); 5.Patients with electrical stimulation of the supraorbital nerve during hospitalization.

Exclusion criteria

Exclusion criteria: 1.Patients with local ulcerative infection or tumor; 2.Patients with severe cardiopulmonary failure; 3.Patients with mental disorder; 4.Serious coagulation disorders; 5.In the course of treatment using nerve block, trigeminal nerve balloon compression,;traditional Chinese medicine treatment and other treatment methods; 6.Receiving other treatment options after discharge; 7.Follow-up failure or incomplete data.

Design outcomes

Primary

MeasureTime frame
Visual analogue scale, VAS;

Countries

China

Contacts

Public ContactZhang Yue

The Affiliated Hospital of Southwest Medical University

zhangyue0518@swmu.edu.cn+86 151 8355 6311

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026